7 results match your criteria: "Neurocenter Finland[Affiliation]"
Stud Health Technol Inform
August 2024
Tampere University Hospital, Neural Medicine Responsibility Sector, Department of Sensory, Neural, and Musculosceletal Medicine, Neurocenter Finland, Tampere Brain and Mind, Wellbeing Services County of Pirkanmaa, Tampere, Finland.
The use of video appointments (VAs) increased significantly during the COVID-19 pandemic. This study investigated the evolution of VA utilisation in Finland using data from two surveys conducted in 2021 (40 responses) and 2023 (30 responses). Our primary aim was to identify patient groups best suited for VAs.
View Article and Find Full Text PDFEur J Neurol
May 2024
Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Background And Purpose: The complex aetiology of Alzheimer's disease suggests prevention potential. Risk scores have potential as risk stratification tools and surrogate outcomes in multimodal interventions targeting specific at-risk populations. The Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) was tested in relation to cognition and its suitability as a surrogate outcome in a multidomain lifestyle randomized controlled trial, in older adults at risk of dementia.
View Article and Find Full Text PDFScand J Caring Sci
December 2021
Institute of Clinical Medicine-Neurology, University of Eastern Finland, Kuopio, Finland.
Background: Availability of genetic testing in neurodegenerative disorders has developed rapidly. This growing ability is providing specific genetic information to individuals and, in turn, their families, raising ethical concerns. However, family members' perspective is a seldom-studied phenomenon.
View Article and Find Full Text PDFAlzheimers Dement
December 2020
Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Introduction: Although not designed as such, dementia risk scores might be useful surrogate outcomes for dementia prevention trials. Their suitability may be improved by using continuous scoring systems, taking into account all changes in risk factors, not only those crossing cut-off values.
Methods: In three large multidomain dementia prevention trials with 1.
BMJ Open
August 2020
Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Objectives: Prevention of cardiovascular disease (CVD) and dementia is a key health priority among older adults. Understanding individuals' attitudes to, the prevention of these conditions, particularly when delivered through novel eHealth tools, could help in designing effective prevention programmes. The aim of the study was to explore the attitudes of older adults at increased risk of CVD and dementia regarding engagement in eHealth self-management prevention programmes, and to describe the facilitators and barriers.
View Article and Find Full Text PDFBMC Geriatr
July 2020
Institute of Clinical Medicine, Department of Neurology, University of Eastern Finland, P.O. Box 1627, 70211, Kuopio, Finland.
Background: The oldest old is the fastest growing age group worldwide and the most prone to severe disability, especially in relation to loss of cognitive function. Improving our understanding of the predictors of cognitive, physical and psychosocial wellbeing among the oldest old can result in substantial benefits for the individuals and for the society as a whole. The Cardiovascular Risk Factors, Aging and Dementia (CAIDE) study investigated risk factors and determinants of cognitive impairment in a population-based longitudinal cohort, which was first examined between 1972 and 1992, when individuals were in their midlife, and re-assessed in 1998 and 2005-2009.
View Article and Find Full Text PDFBMC Geriatr
March 2020
Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Background: A better insight into older adults' understanding of and attitude towards cognitive disorders and their prevention, as well as expectations and reasons for participation in prevention trials, would help design, conduct, and implement effective preventive interventions. This qualitative study aimed at exploring the knowledge and perceptions of cognitive disorders and their prevention among participants in a prevention trial.
Methods: Semi-structured interviews were conducted among the participants of a multinational randomised controlled trial testing the efficacy of a lifestyle-based eHealth intervention in preventing cardiovascular disease or cognitive decline in community dwellers aged 65+.